Sharps Technology Inc

Sharps Technology Inc has a market capitalization of $77.3 million and a price-to-book ratio of 11.27, indicating a premium valuation relative to its book value. The company has no long-term debt and a debt-to-equity ratio of 0.0, suggesting a conservative capital structure. However, its liquidity position is rated as low, and it has a current ratio of 1.15, indicating limited short-term liquidity cushion. The company's profitability metrics are negative, with a return on equity of -14.32% and a return on assets of -10.02%. These figures are below the industry norms for medical equipment and supplies firms, which typically exhibit positive returns on equity and assets. The operating and net losses of $1.84 million and $0.98 million, respectively, further underscore the company's unprofitable operations. Sharps Technology Inc's revenue is not disclosed in the latest financials, but the most recent actual revenue reported by analysts is $7.01 million. The company does not provide segment or geographic breakdowns in the available data, making it difficult to assess revenue concentration or geographic exposure. Without segment data, it is unclear whether the company is diversified or reliant on a single product line or region. The company's growth trajectory is uncertain, as the latest financials show a net loss and negative operating cash flow of $1.89 million. Analysts have not provided forward-looking revenue estimates, and the absence of revenue growth data makes it difficult to project future performance. The company's capital expenditures are minimal, with only $2,850 spent in the latest period, suggesting limited investment in growth or operational expansion. Risk factors for Sharps Technology Inc include its unprofitable operations and negative cash flows, which could impact its ability to sustain operations without external financing. The company has no immediate filing-based liquidity or dilution flags, and its dilution risk is rated as low. However, the absence of long-term debt does not eliminate the possibility of future financing needs, which could lead to equity dilution or increased leverage. Recent events and filings do not indicate any material changes in the company's operations or financial position. The most recent actual revenue reported by analysts is $7.01 million, but there are no recent earnings calls, transcripts, or 10-K filings provided in the data to assess management commentary or strategic direction.